- Home
- BRTX vs ERNA Comparison
BRTX vs ERNA Comparison
Compare BRTX & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- ERNA
- Stock Information
- Founded
- BRTX 1997
- ERNA 2018
- Country
- BRTX United States
- ERNA United States
- Employees
- BRTX N/A
- ERNA N/A
- Industry
- BRTX Managed Health Care
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- BRTX Health Care
- ERNA Health Care
- Exchange
- BRTX Nasdaq
- ERNA Nasdaq
- Market Cap
- BRTX 12.5M
- ERNA 10.2M
- IPO Year
- BRTX N/A
- ERNA N/A
- Fundamental
- Price
- BRTX $1.66
- ERNA $1.34
- Analyst Decision
- BRTX
- ERNA
- Analyst Count
- BRTX 0
- ERNA 0
- Target Price
- BRTX N/A
- ERNA N/A
- AVG Volume (30 Days)
- BRTX 74.0K
- ERNA 201.7K
- Earning Date
- BRTX 11-11-2025
- ERNA 11-11-2025
- Dividend Yield
- BRTX N/A
- ERNA N/A
- EPS Growth
- BRTX N/A
- ERNA N/A
- EPS
- BRTX N/A
- ERNA N/A
- Revenue
- BRTX $605,200.00
- ERNA $488,000.00
- Revenue This Year
- BRTX $232.67
- ERNA N/A
- Revenue Next Year
- BRTX $52.92
- ERNA N/A
- P/E Ratio
- BRTX N/A
- ERNA N/A
- Revenue Growth
- BRTX 247.62
- ERNA 201.24
- 52 Week Low
- BRTX $1.19
- ERNA $1.09
- 52 Week High
- BRTX $2.55
- ERNA $18.75
- Technical
- Relative Strength Index (RSI)
- BRTX 65.28
- ERNA 52.65
- Support Level
- BRTX $1.19
- ERNA $1.09
- Resistance Level
- BRTX $1.47
- ERNA $1.39
- Average True Range (ATR)
- BRTX 0.09
- ERNA 0.09
- MACD
- BRTX 0.02
- ERNA 0.04
- Stochastic Oscillator
- BRTX 100.00
- ERNA 77.42
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.